SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is a randomized, controlled, open-label, multicenter phase III clinical trial, which aims to evaluate the efficacy, safety of SYS6010 compared with monotherapy in participants with HNSCC.
Epistemonikos ID: a9590aae57ad2c688df2227a314bdf2eca7d57df
First added on: Aug 12, 2026